China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,660 | 106,615 | 85,988 | 80,820 | 74,579 |
| Marketable Securities | 38,823 | 72,227 | 71,891 | 63,678 | 63,521 |
| Receivables | 34,419 | 38,329 | 28,539 | 19,403 | 24,668 |
| Inventories | 122,999 | 127,040 | 103,132 | 101,305 | 96,670 |
| TOTAL | $363,965 | $371,999 | $308,416 | $279,987 | $275,447 |
| Non-Current Assets | |||||
| PPE Net | 96,992 | 91,208 | 85,551 | 80,231 | 78,720 |
| Investments And Advances | 9,074 | 9,826 | 18,117 | 18,222 | 13,043 |
| Intangibles | 15,162 | 15,838 | 11,791 | 11,909 | 13,715 |
| Other Non-Current Assets | 43,567 | 16,058 | 16,122 | 56,498 | 52,892 |
| TOTAL | $164,795 | $132,930 | $131,581 | $166,860 | $158,371 |
| Total Assets | $528,760 | $504,929 | $439,997 | $446,847 | $433,818 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 66,300 | 57,903 | 75,700 |
| Accounts payable and accrued liabilities | 58,778 | 61,995 | 48,372 | 54,522 | 46,028 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,525 |
| TOTAL | $66,301 | $68,770 | $122,715 | $120,682 | $128,490 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | 40,000 | 40,000 |
| aiOther Non-Current Liabilities | 1,030 | 569 | 1,618 | 3,815 | -4,037 |
| TOTAL | $12,783 | $10,713 | $10,800 | $50,904 | $46,942 |
| Total Liabilities | $79,084 | $79,483 | $133,514 | $171,585 | $175,433 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,530 | 25,708 | 24,858 | 24,812 | 24,657 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 317,424 | 294,548 | 267,824 | 244,661 | 231,803 |
| Other shareholders' equity | 88,730 | 97,433 | 89,228 | 83,589 | 83,942 |
| TOTAL | $449,676 | $425,446 | $306,483 | $275,262 | $258,385 |
| Total Liabilities And Equity | $528,760 | $504,929 | $439,997 | $446,847 | $433,818 |